NHP Symposium on AIDS - New Orleans

项目总结 此R13会议赠款申请请求资金，以部分支持计划、组织、宣传的成本 并主办第34届艾滋病非人类灵长类模型年度研讨会。本次研讨会将由 由杜兰国家灵长类研究中心(TNPRC)成员举办，将于10月11日至14日举行， 2016年在路易斯安那州新奥尔良的威斯汀新奥尔良运河广场酒店举行。除了资金再- 在这份R13提案中，举办研讨会的费用将从以下机构支付的注册费中获得 会议参与者，以及制药和生物技术公司的贡献。 研讨会的总体形式将包括晚间招待会和登记，然后是两场 以及由特邀演讲者进行的为期半天的科学演讲，以及一个海报会议。《主旨演讲》 将由约瑟夫(迈克)·麦库恩博士主持，并将在国家会议期间举行宴会招待会- 第二次世界大战博物馆。所有口头和海报演示文稿的摘要以及选定的全文论文 将发表在《医学灵长类杂志》(JMP)上，代表艾滋病病毒/艾滋病的最新研究结果 使用非人类灵长类动物(NHP)进行搜索。今年议程上的新增内容包括最新的摘要和 在整个研讨会期间张贴海报。 会议的科学部分将包括平台介绍和海报宣传- 每届会议专门讨论艾滋病研究的一个特定领域。每堂课将由一位受邀的 主席将在会议开幕时作30分钟的发言，联席主席将主持会议-- Sion和讨论。选择摘要的标准将基于原创性和质量 内容。将召开海报会议和招待会，包括不能 在五次口头讲台会议中的一次会议上举行。所有在讲台或海报上发表演讲的个人 将被要求以手稿的形式提交他们的演示文稿，以便在《 罗纳德·维兹博士所著的医学灵长类动物学，他将担任这期特刊的客座编辑 自1989年以来，致力于发表本次年度研讨会的摘要和演讲。 2016年专题讨论会的主要目标是继续作为唯一的科学论坛-- 引用国家卫生计划艾滋病模型和传播最新研究成果和想法 这些模型。最终目标是利用从这些关键的NHP研究中获得的知识来更好地 了解艾滋病毒和SIV是如何导致疾病的。就像许多科学会议一样，交流最新的 实验数据允许与会者修改他们自己的实验设计，以优化成功的机会- 获取、降低成本并确保将NHP用于尽可能最佳的研究。此外，新的合作- 通常会发起诉讼。这种交叉受精也促进了翻译研究，近年来，在- 与会者包括该领域一些最著名的艾滋病毒研究人员。

PROJECT SUMMARY This R13 conference grant application requests funds to partially support the costs to plan, organize, publicize and host the 34th Annual Symposium on Nonhuman Primate Models for AIDS. This symposium will be hosted by members of the Tulane National Primate Research Center (TNPRC), and will be held on October 11-14, 2016 at the Westin New Orleans Canal Place Hotel in New Orleans, Louisiana. In addition to the funds re- quested in this R13 proposal, costs for running the symposium will be obtained from registration fees paid by conference participants, as well as by contributions from pharmaceutical and biotechnology companies. The overall format of the symposium will consist of an evening reception and registration followed by two and a half days of scientific presentations by invited speakers, and a poster session. The “Keynote Address” will be given by Dr. Joseph (Mike) McCune and a mid-conference banquet reception will be held at the Nation- al World War II Museum. Abstracts of all oral and poster presentations as well as selected full-length papers will be published in the Journal of Medical Primatology (JMP) to represent the latest results from HIV/AIDS re- search using nonhuman primates (NHP). Additions to this year's agenda include late-breaker abstracts and display of posters throughout the symposium time period. The scientific portion of the meeting will consist of a combination of platform presentations and poster ses- sions with each session devoted to a specific area of AIDS research. Each session will be led by an invited Chair who will give a 30-minute presentation to open the session, and a Co-Chair who will moderate the ses- sion and discussion. Criteria for selection of the abstracts will be based on the originality and quality of the content. A poster session and reception will be convened to include meritorious presentations that cannot be accommodated in one of the five oral platform sessions. All individuals giving platform or poster presentations will be asked to submit their presentations in manuscript form for publication in a special issue of the Journal of Medical Primatology by Dr. Ronald Veazey who will serve as Guest Editor for the special issue that has been devoted to publishing abstracts and presentations from this Annual Symposium since 1989. The principal objective of the 2016 symposium is to continue to serve as the only scientific forum dedi- cated to NHP models for AIDS and dissemination of the latest research findings and ideas developed from these models. The ultimate goal is to utilize the knowledge gained from these crucial NHP studies to better understand how HIV and SIV cause disease. As is true for many scientific meetings, exchange of the latest experimental data allows attendees to modify their own experimental designs to optimize the chance of suc- cess, reduce costs and ensure that NHPs are used in the best research possible. In addition, new collabora- tions are often initiated. This cross-fertilization also facilitates translational research, and in recent years, at- tendees have included some of the most prominent HIV researchers in the field.